Selskabets formål er at udvikle lægemidler samt dermed beslægtet virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -44 t. | -87 t. | 563 t. | -463 t. | 0 | |
CVR: 37988936
Rikke Stine Friis Fléron joined as director
Sisse Rye Ostrowski left as director
Bo Jesper Hansen registered with 50% ownership
registered with 50% ownership
registered with 50% ownership
Companies in the same industry and area
CVR 45984842
CVR 34668272
CVR 45663205
CVR 44714922
CVR 33871902
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
companydata.dk